Search Results - "TÖRRING, O"

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk by Boonen, S, Adachi, J. D, Man, Z, Cummings, S. R, Lippuner, K, Törring, O, Gallagher, J. C, Farrerons, J, Wang, A, Franchimont, N, San Martin, J, Grauer, A, McClung, M

“…Denosumab treatment for 3 years significantly reduced the incidence of new vertebral and hip fractures in women at higher risk for experiencing these…”
Get full text

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years by Ferrari, S., Adachi, J. D., Lippuner, K., Zapalowski, C., Miller, P. D., Reginster, J.-Y., Törring, O., Kendler, D. L., Daizadeh, N. S., Wang, A., O’Malley, C. D., Wagman, R. B., Libanati, C., Lewiecki, E. M.

“…Summary Limited data exist on the efficacy of long-term therapies for osteoporosis. In osteoporotic postmenopausal women receiving denosumab for 7 years,…”
Get full text

All‐cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism by Giesecke, P., Frykman, V., Wallin, G., Lönn, S., Discacciati, A., Törring, O., Rosenqvist, M.

“…Background Little is known about the long‐term side‐effects of different treatments for hyperthyroidism. The few studies previously published on the subject…”
Get full text

Treatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient by Sjölin, Gabriel, Byström, Kristina, Holmberg, Mats, Törring, Ove, Khamisi, Selwan, Calissendorff, Jan, Lantz, Mikael, Hallengren, Bengt, Filipsson Nyström, Helena, Planck, Tereza, Wallin, Göran

“…Introduction The treatment strategies for a 42‐year‐old female index patient with moderate Graves’ disease (GD) vary according to several international…”
Get full text

Long term outcome after toxic nodular goitre by Sjölin, Gabriel, Watt, Torquil, Byström, Kristina, Calissendorff, Jan, Cramon, Per Karkov, Nyström, Helena Filipsson, Hallengren, Bengt, Holmberg, Mats, Khamisi, Selwan, Lantz, Mikael, Planck, Tereza, Törring, Ove, Wallin, Göran

“…Background The purpose of treating toxic nodular goitre (TNG) is to reverse hyperthyroidism, prevent recurrent disease, relieve symptoms and preserve thyroid…”
Get full text

The Role of Adrenal Scintigraphy in the Preoperative Management of Primary Aldosteronism by Volpe, C., Enberg, U., Sjögren, A., Wahrenberg, H., Jacobsson, H., Törring, O., Hamberger, B., Thorén, M.

“…Background and Aims: Differentiation between the two major subgroups of primary aldosteronism, bilateral hyperplasia and aldosterone producing adenoma is…”
Get full text

Denosumab effects on radius BMD, estimated strength, and wrist fractures: 3-year results from the FREEDOM study by Törring, O, Simon, J, Recknor, C, Moffet, A, Adachi, J, Franek, E, Lewiecki, E, Mautalen, C, Eis, S. Ragi, Nicholson, G, Muschitz, C, Nuti, R, Wang, A, Libanati, C

Get full text

Medical Observation, Compared with Parathyroidectomy, for Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial by Bollerslev, Jens, Jansson, Svante, Mollerup, Charlotte L., Nordenström, Jörgen, Lundgren, Eva, Tørring, Ove, Varhaug, Jan-Erik, Baranowski, Marek, Aanderud, Sylvi, Franco, Celina, Freyschuss, Bo, Isaksen, Gunhild A., Ueland, Thor, Rosen, Thord

“…Context: The clinical presentation of primary hyperparathyroidism (pHPT) has changed during the last half century, and the diagnosis is now more often made by…”
Get full text

Osteonecrosis of the Jaw in Sweden Associated With the Oral Use of Bisphosphonate by Ulmner, Mattias, DDS, Jarnbring, Fredrik, DDS, Törring, Ove, MD, PhD

“…Purpose To estimate the incidence of bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) associated with the use of oral BPs and osteonecrosis of the…”
Get full text

Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia by Hedberg, Fredric, Pilo, Christina, Wikner, Johan, Törring, Ove, Calissendorff, Jan

“…Abstract Gene variants of CYP24A1, which encodes the enzyme 24-hydroxylase, are a most unusual cause of maternal hypercalcemia. Loss-of-function mutations in…”
Get full text

Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery by Abraham-Nordling, Mirna, Törring, Ove, Hamberger, Bertil, Lundell, Göran, Tallstedt, Leif, Calissendorff, Jan, Wallin, Göran

“…The effects of treatment modality for Graves' disease (GD) were studied with respect to long-term quality of life and present health status. A total of 179…”
Get more information

A methodology for comparing optimization algorithms for auto-tuning by Willemsen, Floris-Jan, Schoonhoven, Richard, Filipovič, Jiří, Tørring, Jacob O., van Nieuwpoort, Rob, van Werkhoven, Ben

“…Adapting applications to optimally utilize available hardware is no mean feat: the plethora of choices for optimization techniques are infeasible to maximize…”
Get full text

Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations by Lantz, Mikael, Calissendorff, Jan, Träisk, Frank, Tallstedt, Leif, Planck, Tereza, Törring, Ove, Hallengren, Bengt, Åsman, Peter

“…Background: Orbital morphological changes are often present in patients with Graves' disease (GD) already at diagnosis, and cyclooxygenase type 2 (COX-2) is…”
Get full text

Graves' hyperthyroidism : Treatment with antithyroid drugs, surgery, or radioiodine : A prospective, randomized study by TÖRRING, O, TALLSTEDT, L, WALLIN, G, LUNDELL, G, LJUNGGREN, J.-G, TAUBE, A, SÄÄF, M, HAMBERGER, B

Get full text

Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group by Törring, O, Tallstedt, L, Wallin, G, Lundell, G, Ljunggren, J G, Taube, A, Sääf, M, Hamberger, B

“…To analyze the benefits and risks of three common treatments, we randomly assigned 179 patients with Graves' hyperthyroidism as follows: 60 patients, 20-34 yr…”
Get full text

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism by Tallstedt, Leif, Lundell, Göran, Tørring, Ove, Wallin, Göran, Ljunggren, Jan-Gustaf, Blomgren, Henric, Taube, Adam

“…THE two most common components of Graves' disease are hyperthyroidism and ophthalmopathy. There is usually a close temporal relation between the onset of the…”
Get full text

Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells by Tsai, J A, Janson, A, Bucht, E, Kindmark, H, Marcus, C, Stark, A, Zemack, H Rawet, Torring, O

“…Extra-thyroidal thyrotropin (TSH) receptors (TSHRs) have been demonstrated in several tissues and cells, including human and rat osteosarcoma cell lines. We…”
Get full text

Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats by Ejersted, Charlotte, Andreassen, T.T., Oxlund, H., Jørgensen, P.H., Bak, B., Häggblad, J., Tørring, O., Nilsson, M.H.L.

“…An anabolic effect on bone of intermittent parathyroid hormone (PTH) treatment has been found in patients with osteoporosis and also in experimental animals…”
Get full text

Calcium and vitamin D3 supplements in calcium and vitamin D3 sufficient early postmenopausal healthy women by Tfelt-Hansen, J, Torring, O

“…Objective: To study the calcium homeostasis in healthy, calcium and vitamin D replete early postmenopausal women during oral supplementation with calcium and…”
Get full text

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84) by Mosekilde, L, Søgaard, C H, Danielsen, C C, Tørring, O

“…PTH has a proven anabolic effect on bone mass, as has been shown in several animal models and treatment regimens. The aim of this study was to ascertain…”
Get more information